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Engagement of cytokine receptors by specific ligands activate Janus kinase–signal transducer  
and activator of transcription (STAT) signaling pathways. The exact roles of STATs in human 
lymphocyte behavior remain incompletely defined. Interleukin (IL)-21 activates STAT1 and STAT3 
and has emerged as a potent regulator of B cell differentiation. We have studied patients with 
inactivating mutations in STAT1 or STAT3 to dissect their contribution to B cell function in vivo 
and in response to IL-21 in vitro. STAT3 mutations dramatically reduced the number of func-
tional, antigen (Ag)-specific memory B cells and abolished the ability of IL-21 to induce naive  
B cells to differentiate into plasma cells (PCs). This resulted from impaired activation of the 
molecular machinery required for PC generation. In contrast, STAT1 deficiency had no effect  
on memory B cell formation in vivo or IL-21–induced immunoglobulin secretion in vitro. Thus, 
STAT3 plays a critical role in generating effector B cells from naive precursors in humans.  
STAT3-activating cytokines such as IL-21 thus underpin Ag-specific humoral immune responses 
and provide a mechanism for the functional antibody deficit in STAT3-deficient patients.
© 2010 Avery et al.  This article is distributed under the terms of an Attribution–
  Noncommercial–Share Alike–No Mirror Sites license for the first six months after   
the publication date (see http://www.jem.org/misc/terms.shtml). After six months   
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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exhibit poor Ag-specific Ab responses after immunization 
with T cell–dependent (TD) Ag (Dreskin et al., 1985; Leung 
et al., 1988; Sheerin and Buckley, 1991). Consequently, 
they suffer from an increased incidence of infections with 
encapsulated organisms (Streptococcus pneumoniae, Haemophilus 
influenzae), a scenario consistent with a B cell defect manifesting 
as functional Ab deficiency (Dreskin et al., 1985; Leung et al., 
1988; Sheerin and Buckley, 1991).
The mechanisms underlying some of the clinical features 
of AD-HIES are being unraveled. Elucidation of the T cell–
intrinsic actions of STAT3 revealed that the unique suscepti-
bility of these patients to infections at epithelial surfaces is 
caused by a deficiency of Th17 cells (de Beaucoudrey et al., 
2008; Ma et al., 2008; Milner et al., 2008; Renner et al., 
2008; Minegishi et al., 2009). These studies highlighted the 
utility  of  analyzing  lymphocyte  differentiation  in  patients 
with defined molecular lesions as a strategy of understanding 
key clinical features of immunodeficient conditions. Despite 
this progress, the mechanism underlying reduced Ag-specific 
Ab responses, despite normal serum Ig levels, in patients with 
STAT3 mutations is unknown. Thus, it is of considerable in-
terest to understand the B cell–intrinsic function of STAT3.
Studies of gene-modified mice and of human B cells in 
vitro have revealed that IL-21 is a key cytokine for establish-
ing, maintaining, and regulating the quality of Ab responses   
(Ozaki et al., 2002; Ozaki et al., 2004; Pène et al., 2004;   
Bryant et al., 2007; Avery et al., 2008a,b; Ettinger et al., 2008; 
Nurieva et al., 2008; Vogelzang et al., 2008). IL-10 is also 
capable of inducing Ig secretion from human B cells, albeit to 
a much lesser extent than IL-21 (Rousset et al., 1992; Brière 
et al., 1994; Bryant et al., 2007). Importantly, these cytokines 
are capable of activating STAT3 (Asao et al., 2001; Habib   
et al., 2002; Zeng et al., 2007; Diehl et al., 2008). Based on this, 
we hypothesized that impaired responsiveness to IL-10 and 
IL-21 may account for the functional Ab deficiency in AD-
HIES patients. We found that STAT3 plays a critical role in 
generating memory cells and plasma cells (PCs) from naive 
precursors in vivo and in vitro in response to IL-10 and IL-21.   
This function of STAT3 is nonredundant because similar defects 
were not observed in the context of mutations in STAT1. 
This reveals that STAT3-activating cytokines, predominantly 
IL-21, are key mediators of human B cell effector function 
and humoral immune responses, and importantly, provides a 
mechanism for the functional Ab deficit in AD-HIES patients.
RESULTS
IL-21 predominantly activates STAT1 and STAT3  
in primary human B cells
IL-21 can activate STAT1, STAT3, and STAT5, and the 
mitogen-activated protein kinase and Akt pathways (Asao 
et al., 2001; Zeng et al., 2007; Diehl et al., 2008). To extend 
these studies, human splenic B cells were stimulated with 
CD40L and anti-Ig for 24 h and then exposed to IL-21. 
STAT1  and  STAT3  became  maximally  phosphorylated 
within 15–30 min of IL-21 exposure and returned to basal 
levels by 60 min (Fig. 1, A and B). In contrast, there was only 
Human antibody (Ab) deficiency disorders are the most 
common form of primary immunodeficiency (Cunningham- 
Rundles and Ponda, 2005; Fischer, 2007). Many of these 
patients have absolute deficiency of serum Ig and are diagnosed 
with common variable immunodeficiency (CVID). Interest-
ingly, individuals with normal serum IgG can nonetheless expe-
rience recurrent invasive infections with encapsulated organisms 
or have defects in establishing antigen (Ag)-specific Ab re-
sponses (Cunningham-Rundles and Ponda, 2005; Fischer, 2007). 
These clinical observations indicate that intrinsic functional B 
cell defects have significant consequences for host defense, 
even though they may not manifest as hypogammaglobulinemia. 
With the exception of the hyper-IgM syndromes caused 
by mutations in CD40, AICDA, and UNG (Cunningham-
Rundles and Ponda, 2005), we have very little insight into the 
mechanisms underlying these intrinsic B cell defects.
Differentiation of naive lymphocytes into effector cells is 
regulated in part by signals delivered through cytokine recep-
tors and subsequent activation of JAK–STAT signaling path-
ways (Akira, 1999; Shuai and Liu, 2003; O’Shea and Murray, 
2008). Four JAK and seven STAT proteins have been identified, 
and germline or conditional deletion has revealed important 
roles for specific JAK–STAT pathways in the development 
and differentiation of multiple cell lineages (Akira, 1999; Shuai 
and Liu, 2003; O’Shea and Murray, 2008). Furthermore, 
mutations in JAK3, TYK2, STAT1, and STAT5B are associ-
ated with human immunodeficiencies (Macchi et al., 1995; 
Dupuis et al., 2003; Bernasconi et al., 2006; Minegishi et al., 
2006; Fischer, 2007), underscoring the fundamental role of 
these molecules in immune regulation.
Recently, heterozygous mutations in STAT3 have been 
found to cause 60% of cases of autosomal dominant hyper-
IgE syndrome (AD-HIES; Holland et al., 2007; Minegishi 
et al., 2007). Most mutations act in a dominant-negative 
(DN) manner, reducing the number of functional STAT3 
dimers by 75% (Minegishi et al., 2007). In contrast to all 
other STATs, germline deletion of Stat3 is embryonically 
lethal  (Akira,  1999).  Thus,  although  residual  functional 
STAT3 dimers in AD-HIES allow placental development, 
they are insufficient to prevent disease. Because STAT3 is 
widely expressed and activated by >25 cytokines (O’Shea 
and Murray, 2008; Tangye et al., 2009), it is not surprising 
that AD-HIES is a multisystem disease affecting the immune 
and musculoskeletal systems. Immunological defects include 
skin lesions (eczema, boils), recurrent invasive mucocutane-
ous and lung infections with Staphylococcus aureus and Can-
dida  albicans,  and  high  levels  of  IgE  (Davis  et  al.,  1966; 
Grimbacher et al., 2005; Tangye et al., 2009). The dysregu-
lation underlying increased serum IgE in AD-HIES patients 
remains to be established. It does not appear to result from 
an intrinsic B cell defect that results in enhanced switching 
to IgE (Avery et al., 2008b) but may reflect altered produc-
tion of regulatory cytokines by CD4+ T cells (Ma et al., 
2008) and defects at epithelial surfaces (Grimbacher et al., 
2005; Tangye et al., 2009). Although AD-HIES patients 
have normal serum levels of IgM, IgG, and IgA, many   JEM VOL. 207, January 18, 2010 
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transitional (CD10+CD27), whereas 25–35% are memory 
(CD27+; Fig. 2, A–C; Klein et al., 1998; Tangye et al., 1998;   
Wardemann et al., 2003; Ma et al., 2005; Ma et al., 2006;   
Avery et al., 2008b). Within the CD27+ B cell population of 
normal donors (5–65 yr old), 50, 25, and 20% of them   
express IgM, IgG, or IgA, respectively (Fig. 2 D; Ma et al., 
2005; Ma et al., 2006). Analysis of 10 STAT3MUT and 6 
STAT1MUT patients demonstrated no significant difference 
(P > 0.05) in the frequencies of total PB B cells compared 
with normal controls (Fig. 2 A). However, the frequencies 
of transitional and naive cells were increased and memory 
cells were dramatically reduced (P < 0.01; Fig. 2, B and C) 
in STAT3MUT patients compared with healthy donors. The   
defect  in  memory  cell  generation  was  observed  for  all   
patients examined irrespective of their STAT3 mutation, in 
contrast to patients with elevated serum IgE levels but WT 
STAT3, or patients with STAT1 mutations—who had nor-
mal frequencies of B cell subsets (Fig. 2, A–C)—and a large 
cohort of CVID patients, of whom 50% had a memory 
B cell deficit (Fig. 2 C). We also detected normal percentages 
of IgG+ memory cells (32.1 ± 4.7%; range: 24.5–45.4%) in 
STAT1MUT patients (n = 5), suggesting that memory B cell 
generation is normal in these individuals. Thus, intact signal-
ing through STAT3 is required to generate the memory   
B cell pool, whereas signaling through STAT1 is dispensable 
for memory B cell formation.
Notably, the distribution of nonswitched and switched 
B cells within the CD27+ subset from normal donors and 
STAT3MUT patients was similar, with 50% expressing IgM 
and 40% having undergone switching to express IgG or 
IgA (Fig. 2 D). There was a significant increase and decrease 
in the frequencies of IgG+ and IgA+ memory cells, respec-
tively, in STAT3MUT patients compared with healthy con-
trols (Fig. 2 D). Because B cells need to undergo greater 
rounds of proliferation to switch to IgA than they do for IgG 
(Deenick et al., 1999; Avery et al., 2008a), these differences 
in frequencies of IgG+ and IgA+ memory B cells may reflect 
in vivo defects in the proliferation of STAT3MUT B cells (see 
Proliferation and survival induced by...). These phenotypic 
features of memory B cells from STAT3MUT patients starkly   
contrast patients with mutations in CD40LG, CD40, IKBKG, 
ICOS, or SH2D1A, whose few memory B cells fail to undergo 
isotype switching (Tangye and Tarlinton, 2009), and CVID 
patients who display great heterogeneity in the nature of the 
Ig isotype expressed by their cells (Fig. 2 D).
STAT3MUT AD-HIES patients fail to generate  
Ag-specific effector B cells
The importance of STAT3 in generating memory B cells is 
consistent with previous findings of defective functional 
Ab responses in AD-HIES patients (Dreskin et al., 1985; 
Leung et al., 1988; Sheerin and Buckley, 1991). One caveat 
of these studies is that they predated the discovery that 
STAT3 mutations caused this condition. Thus, the molecular 
lesion in the patients studied was unknown. This is particu-
larly relevant because STAT3 mutations cause AD-HIES   
a low level of phospho-STAT5 detected in IL-21–stimulated 
human B cells and no difference in the phosphorylation status 
of STAT6 in B cells cultured with or without IL-21 (Fig. 1, 
A and B). Thus, IL-21 predominantly activates STAT1 and 
STAT3 in human B cells.
STAT1 and STAT3 mutant patients
To dissect the molecular mechanism whereby IL-21 activates 
human B cells, we analyzed B cell development and effector 
function in individuals with mutations in STAT1 or STAT3. 
We  studied  10  patients  with  STAT3  mutations.  All  had   
aberrantly high levels of serum IgE, a Th17 deficiency, and 
heterozygous mutations in the DNA-binding, Src homol-
ogy 2, or transactivation domains of STAT3 (Table S1; Ma 
et al., 2008). We also examined six patients who had either 
homozygous (Chapgier et al., 2006b; Chapgier et al., 2009) or 
heterozygous DN mutations (Dupuis et al., 2001; Chapgier 
et al., 2006a) in STAT1 (Table S2).
We examined IL-21–induced STAT phosphorylation in 
EBV-transformed  lymphoblastoid  cell  lines  (EBV-LCLs) 
from patients with heterozygous mutations in STAT3 (n = 5), 
complete STAT1 deficiency (n = 3; Dupuis et al., 2003; 
Chapgier et al., 2006b), or partial STAT1 deficiency with 
homozygous (n = 1; Chapgier et al., 2009) or heterozygous 
(n = 4; Dupuis et al., 2001; Chapgier et al., 2006a) STAT1 
mutations. Stimulation of normal LCLs with IL-21 resulted   
in robust phosphorylation of both STAT1 and STAT3 (Fig. 1, 
C and D). STAT1 and STAT3 were also phosphorylated in 
IL-21–stimulated LCLs from STAT3 mutant (STAT3MUT) 
patients, irrespective of the location of the STAT3 mutation, 
or patients with DN STAT1 mutations, with the levels   
falling within the ranges established for normal LCLs (Fig. 1 
D and Fig. S1). IL-21 also activated STAT3 in LCLs from 
patients who lacked STAT1 (Fig. 1, C and D). Because of the 
deficiency of STAT1 in these cell lines, no phospho-STAT1 
was detected. IL-21 induced only modest phospho-STAT5 
in normal and STATMUT LCLs, whereas it did not activate 
STAT6 in any of these LCLs (Fig. 1 C, D). Thus, consistent 
with the findings by us (Fig. 1, A and B) and others (Diehl   
et al., 2008) for primary human B cells, IL-21 predominantly 
activates STAT1 and STAT3 even in the presence of muta-
tions in these signaling molecules.
STAT3 deficiency impairs the in vivo generation  
of human memory B cells in AD-HIES patients
The ability of IL-21 to activate STAT1 and STAT3, and the 
important role of IL-21 in regulating B cell responses (Ozaki 
et al., 2002; Pène et al., 2004; Bryant et al., 2007; Avery   
et  al.,  2008a,b;  Diehl  et  al.,  2008;  Ettinger  et  al.,  2008)   
suggested that patients with STAT1 or STAT3 mutations 
may have defects in B cell differentiation in vivo. Thus, we 
examined the generation of memory cells in these patients.
Human B cells can be resolved into subsets of transi-
tional, naïve, and memory cells by the differential expression   
of CD10 and CD27. In normal donors, 15% of peripheral 
blood (PB) lymphocytes are B cells; 10% of these are   158 STAT3 deficiency impairs B cell differentiation | Avery et al.
Figure 1.  IL-21 predominantly activates STAT1 and STAT3 in primary human B cells. (A and B) Human splenic B cells were cultured for 24 h with 
CD40L plus anti-Ig and then cultured in the absence (red) or presence (blue) of IL-21. Phosphorylation of STAT1, 3, 5, and 6 was determined by intracellular stain-
ing. (A) Expression of phospho-STATs after 30 min. (B) Kinetics of IL-21–induced STAT phosphorylation in primary human B cells. These results are representative 
of two (STAT5 and 6) or three (STAT1 and 3) experiments. (C) Expression of phospho-STATs in EBV-LCLs from normal controls or patients with mutations in STAT3 
or STAT1 that were cultured without (red) or with (blue) IL-21 for 30 min. (D) Induction of phospho-STATs in cell lines examined from the indicated number of 
normal donors (red squares) and STAT3MUT (black triangles, Src homology 2 domain mutations; blue triangles, DNA-binding domain mutations; green triangles, 
transactivation domain mutations) and STAT1MUT patients (orange circles) in response to IL-21. The values represent the fold increase in mean fluorescence inten-
sity of cells stimulated with IL-21 for 30 min over unstimulated cells. The symbols correspond to the mean derived from one to four experiments performed on 
each cell line; the horizontal bars represent means. The dashed lines indicate a fold change of 1, which represents no change in expression of phospho-STAT 
proteins in the presence of IL-21. DNABD, DNA-binding domain; MFI, mean fluorescence intensity; SH2, Src homology 2 domain; TA, transactivation domain.JEM VOL. 207, January 18, 2010 
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Figure 2.  Mutations in STAT3 severely compromise the generation of memory B cells. (A–C) The frequencies of total B cells (A) or transitional 
(CD20+CD10+CD27), naive (CD20+CD10CD27), and memory (CD20+CD10CD27+) B cells (B and C) in healthy donors (HD; n = 26–32), STAT3MUT  
patients (n = 10), patients with AD-HIES but WT STAT3 alleles (HIES; n = 4–5), STAT1MUT patients (n = 5–6), or CVID patients (n = 36) were determined by 
flow cytometry. The values in B correspond to the frequencies (means ± SEM) of transitional (T), naive (N), and memory (M) B cells in the indicated donor 
populations. (D) memory (CD20+CD10CD27+) B cells from healthy donors (HD; n = 32), STAT3MUT patients (n = 10), WT STAT3 AD-HIES patients (n = 5), 
and CVID patients (n = 31) were labeled with mAbs specific for IgM, IgG, or IgA. The frequency of memory B cells that were IgM+, IgG+, or IgA+ was then 
determined. The plots in A and B are from representative healthy donors and patients; the graphs in A, C, and D show data points for all donors and  
patients examined, and the horizontal bars represent means. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
in only 60% of patients (Minegishi et al., 2007). Moreover, 
there is some controversy regarding the appropriate criteria 
by which human B cells are categorized as memory cells 
(Tangye and Tarlinton, 2009). Thus, to confirm a role for 
STAT3 mutations in causing a functional memory B cell and 
Ab deficiency, we assessed Ag-specific B cell responses in our 
cohort of STAT3MUT patients by adopting an approach that 
made no assumptions about the phenotype of memory cells.160 STAT3 deficiency impairs B cell differentiation | Avery et al.
more specific Ag (Fig. 3 F). Thus, production of high titer   
and  high-affinity  Ag-specific  Ig  requires  intact  signaling 
through STAT3.
Proliferation and survival induced by IL-10 and IL-21  
is compromised in STAT3MUT naive B cells
To better understand how mutations in STAT3, but not 
STAT1, might compromise the generation of both memory 
cells and PCs, the functional consequences of such loss-of-
function mutations on the responses of human B cells in vitro 
were investigated. We first examined the ability of IL-21 
to augment proliferation of naive control, STAT3MUT, and 
STAT1MUT B cells induced by CD40L, as revealed by CFSE 
dilution over a 5-d culture. We also investigated responses to 
IL-10, because it activates STAT3 and enhances human B 
cell  proliferation  and  differentiation,  although  to  a  much 
lesser extent than IL-21 (Fig. S1; Rousset et al., 1992; Leonard, 
2001; Bryant et al., 2007; Ettinger et al., 2008; O’Shea and 
Murray, 2008). IL-4 was also examined as it predominantly 
activates STAT6 (Leonard, 2001).
Naive B cells from healthy donors and STAT3MUT and 
STAT1MUT  patients  exhibited  identical  proliferative  re-
sponses after stimulation with CD40L alone or CD40L/IL-4   
(Fig. 4, A and B). In contrast, expansion of CD40L-stimulated 
STAT3MUT and STAT1MUT B cells to IL-10 and/or IL-21   
Total B cells were cultured with CD40L, CpG, S. au-
reus Cowan I (SAC; to engage the BCR), IL-10, and IL-21 
for 4 d and recultured for another 3 d. The frequencies of 
cells  secreting  IgM,  IgG,  or  antitetanus  IgG  were  then   
determined. This assay relies on the in vitro differentiation 
of Ag-specific memory B cells into Ig-secreting cells (ISCs). 
Under these conditions, 10–15% of control B cells differ-
entiated  into  ISCs  (Fig.  3  A)  and  produced  substantial   
quantities of Ig during the secondary culture (Fig. 3 B). 
Furthermore, the IgG-ISCs contained a detectable popu-
lation  of  tetanus-specific  B  cells  (Fig.  3  C).  Although 
STAT3MUT B cells also yielded polyclonal ISCs, the fre-
quency and amount of Ig secreted was approximately three- 
to  sixfold  less  than  control  B  cells  (Fig.  3,  A  and  B). 
Moreover, we were unable to detect Ag-specific cells in 
any of the STAT3MUT patients examined (Fig. 3 C). We 
also measured antitetanus IgG secreted by cultured B cells. 
The levels of tetanus-specific IgG produced by control B 
cells exceeded STAT3MUT B cells by >30-fold (Fig. 3 D). 
This correlated with reduced levels of these Abs in the serum 
of STAT3MUT patients (Fig. 3 E). When the relative affinity 
of antitetanus IgG in the sera of controls and STAT3MUT 
patients was compared, the half-maximal binding of control 
sera to immobilized tetanus occurred at 100 ng/ml teta-
nus,  whereas  STAT3MUT  sera  required  at  least  10-fold 
Figure 3.  STAT3 deficiency impairs the generation of Ag-specific memory B cells in vivo. B cells from healthy controls or STAT3MUT patients 
were cultured with CD40L, CpG, SAC, IL-10, and IL-21 for 4 d and were recultured for 3 d. The proportion of cells secreting (A) IgM+IgG or (C) anti-
tetanus IgG was determined by ELISPOT. (B) Levels of total Ig (IgM+IgG+IgA) secreted during the secondary culture were determined by ELISAs; the results 
are expressed as micrograms of Ig secreted per 105 input cells in the secondary culture. Each symbol represents the response from an individual con-
trol or patient; the horizontal bars represent means. (D and E) Levels of antitetanus IgG in culture supernatants (Sn; D) or serum (E) from normal 
controls or STAT3MUT patients were determined by ELISA. (F) Sera from controls or STAT3MUT patients (1:40 dilution) were incubated with decreasing 
amounts of immobilized tetanus toxoid. Binding of antitetanus IgG was determined by ELISA. The results are expressed as the percentage of maximum 
binding, which is defined as the binding to the highest concentration of tetanus (i.e., 3 µg/ml). In D, the data for the controls represent means ± SEM 
from eight control donors; each blue line represents data from an individual STAT3MUT patient (n = 8). The data in E and F represent means ± SEM from 
four control donors and five STAT3MUT patients.JEM VOL. 207, January 18, 2010 
Article
161
exceeded that of CD40L alone. Thus, loss of STAT1 and 
STAT3 function compromises the proliferation-enhancing 
effects of IL-10 and IL-21 on CD40L-stimulated B cells.
was reduced (Fig. 4, A and B). Despite the reduced prolif-
eration of STAT3MUT and STAT1MUT B cells to IL-10 or 
IL-21, the extent of cell division induced by these cytokines 
Figure 4.  Mutations in STAT3 or STAT1 partially reduce IL-10– and IL-21–mediated proliferation and survival of CD40L-activated B cells. 
(A and B) Naive B cells were sort purified from healthy controls, STAT3MUT patients, or a STAT1MUT patient; labeled with CFSE; and cultured for 5 d with 
CD40L alone or together with IL-4, IL-10, or IL-21. (A) CFSE profiles of control and STAT3MUT naive B cells stimulated under the indicated conditions.  
(B) Frequency of B cells in each division; the values for the control and STAT3MUT B cells represent means ± SEM from five independent experiments. Data for 
STAT1MUT B cells are from a single experiment. (C and D) Naive B cells from healthy controls or STAT3MUT patients were cultured for 3 d with CD40L alone 
or together with IL-10 or IL-21. (C) The percentage of apoptotic cells was determined by annexin V staining. The values represent the mean percentage of 
annexin V+ cells. (D) The number of viable cells recovered from each culture was also determined. (E and F) Expression of IL-10R (red; E) and IL-21R (red; F) 
on naive B cells was determined by flow cytometry. The overlays (blue) represent isotype control mAb. The values are means ± SEM (n = 4) of the fluorescence 
intensity of cells labeled with the isotype control or anti–IL-10R or –IL-21R mAb.162 STAT3 deficiency impairs B cell differentiation | Avery et al.
Figure 5.  Isotype switching, AICDA expression, and SHM are unaffected by mutations in STAT3 or STAT1. Naive B cells from (A) normal con-
trols, (B) STAT3MUT patients, or (C) a STAT1MUT patient were labeled with CFSE; cultured for 5 d with CD40L alone or together with IL-4, IL-21, or IL-4/IL-21; 
and analyzed for division and expression of surface IgG. A–C depict contour plots from one experiment. (D) Frequency of IgG+ (±SEM) cells in each  
division (control and STAT3MUT: n = 7; STAT1MUT: n = 1). (E) Naive B cells from healthy controls or STAT3MUT or STAT1MUT patients were cultured with CD40L 
alone or with IL-21. After 5 d, expression of AICDA was determined by quantitative PCR. The results are means ± SEM (control: n = 12; STAT3MUT: n = 7; or  JEM VOL. 207, January 18, 2010 
Article
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STAT3-activating cytokines can promote B cell survival 
in vitro (Levy and Brouet, 1994; Otero et al., 2006). Thus, 
we were interested in determining whether such prosurvival 
effects were affected by STAT3 mutations. Naive B cells 
were cultured with CD40L alone or together with IL-10 or 
IL-21, and the level of apoptosis and the number of surviving 
cells were determined after 3 d. Fewer STAT3MUT B cells 
survived in vitro in response to CD40L than normal B cells 
(Fig. 4, C and D). IL-10 had no effect on apoptosis (Fig. 4 C) 
but modestly increased the recovery of viable cells in cultures   
of normal, but not STAT3MUT, naive B cells (Fig. 4 D).   
IL-21  reduced  apoptosis  and  improved  survival  of  both 
control and STAT3MUT B cells (Fig. 4, C and D). Thus, 
STAT3MUT B cells have an intrinsic defect in survival irre-
spective of the mode of in vitro stimulation. Furthermore, 
IL-10 and IL-21 differ in their abilities and mechanisms to 
support the survival of in vitro–cultured B cells, with the   
effect of IL-10 but not IL-21 being STAT3 dependent.
Several cytokines regulate expression of their cognate re-
ceptor. Thus, it was possible that reduced function of IL-10 
and IL-21 on human naive STAT3MUT B cells reflected differ-
ences in expression of their receptors. However, naive B cells 
from healthy controls and STAT3MUT patients displayed com-
parable levels of IL-10R and IL-21R (Fig. 4, E and F). Thus, 
the reduced responses of STAT3MUT B cells to the stimula-
tory effects of IL-21 and IL-10 reflect impaired STAT3-
dependent  signaling  rather  than  reduced  expression  of 
cytokine receptors.
IL-21–induced isotype switching to IgG is unaffected  
by mutations in STAT3 or STAT1
Although total memory cells were decreased in STAT3MUT 
patients, the finding that the proportion of IgG+ and IgA+ 
cells within their memory compartment approximated normal 
donors suggested that isotype switching occurred normally 
in vivo despite mutations in STAT3. Because IL-10 and IL-21 
can induce switching to IgG (Brière et al., 1994; Pène et al., 
2004; Avery et al., 2008a; Ettinger et al., 2008) and the effect 
of IL-21 is enhanced by IL-4 (Avery et al., 2008a), we tested 
whether naive STAT3MUT and STAT1MUT B cells could switch 
to IgG in response to IL-10, IL-21, and/or IL-4. Although 
CD40L had no effect on isotype switching by control B cells, 
addition of IL-4 or IL-21 generated comparable frequencies 
(3–5%) of IgG+ cells, and this frequency was increased 
approximately four- to fivefold by the combination of IL-4 
plus IL-21 (Fig. 5 A; Tangye et al., 2002; Avery et al., 2008a). 
CD40L-stimulated naive STAT3MUT B cells also underwent 
isotype switching to IL-4 and IL-21 alone or in combination 
(Fig. 5 B). However, approximately two- to threefold fewer 
IgG+ cells were generated compared with control naive B 
cells (Fig. 5 B). In contrast, STAT1MUT B cells yielded normal 
frequencies of IgG+ B cells (Fig. 5 C). IL-10 induced few 
normal or STAT3MUT naive B cells to switch to IgG (Fig. S2, 
A and B; Tangye et al., 2002). This was consistent with a   
lack of induction of phospho-STAT1 and reduced phospho-
STAT3 (Fig. S1), and proliferation (Fig. 4, A and B) in IL-10–
stimulated B cells compared with IL-21. Thus, it was difficult 
to ascertain whether isotype switching induced by IL-10 was 
compromised by STAT3 mutations.
Ig isotype switching is linked to cell division (Hodgkin 
et al., 1996; Deenick et al., 1999; Tangye et al., 2002). Because 
there was a profound defect in proliferation of naive STAT3MUT 
B cells to IL-21 (Fig. 4, A and B), it was important to investi-
gate isotype switching in the context of cell division. CD40L/
IL-4  or  CD40L/IL-4/IL-21  induced  fewer  (25–40%) 
switched B cells per division from STAT3MUT B cells com-
pared with normal B cells, suggesting that STAT3 plays a role 
in IL-4–induced switching to IgG (Fig. 5 D). This is likely 
because of the ability of IL-4 to activate STAT3 in human B 
cells via the IL-4R–IL-13R1 complex, which functions 
as the IL-13R as well as an alternative IL-4R (Umeshita-
Suyama et al., 2000). In contrast, the division-based rate of 
isotype  switching  by  STAT3MUT  B  cells  in  response  to 
CD40L/IL-21 was similar to normal B cells (Fig. 5 D). Thus, 
the reduced frequency of IgG+ cells generated from STAT3MUT 
B cells as detected at the bulk population resulted from the 
cells undergoing fewer rounds of division. Not surprisingly, 
the division-based rate of switching of STAT1MUT B cells in 
response to IL-4 and IL-21 was intact (Fig. 5 D).
The observations of normal isotype switching by STAT3MUT 
and STAT1MUT B cells in vivo and in vitro prompted us to 
examine expression of AICDA, which is required for isotype 
switching (Muramatsu et al., 2000). IL-21 increased AICDA 
expression in CD40L-stimulated normal, STAT3MUT, and 
STAT1MUT naive B cells by 5–10-fold compared with that 
induced by CD40L alone (Fig. 5 E). In contrast, IL-10 failed to 
induce AICDA expression in normal and STAT3MUT naive B 
cells (Fig. S2 C). Thus, IL-21–induced expression of AICDA and 
subsequent class switching can occur despite impaired signal-
ing through STAT1 or STAT3.
STAT3MUT memory B cells undergo somatic hypermutation 
(SHM) in vivo
AICDA is also required for SHM (Muramatsu et al., 2000). 
Thus, we assessed SHM in the few memory cells detectable 
in STAT3MUT patients. Most Ig VH5 genes isolated from 
normal (18 out of 19; 94.7%) and STAT3MUT (24 out of 26; 
92.3%) naive B cells contained zero to one mutations (normal: 
0.52 ± 0.14; STAT3MUT: 0.35 ± 0.14; Fig. 5 F), and 14 out 
of 15 VH5 gene sequences from normal memory B cells   
harbored mutations (5.1 ± 1.04 mutations/sequence; Fig. 5,   
F and G). In contrast, only 13 out of 23 (56.5%) VH5 gene 
STAT1MUT: n = 3 experiments) and are expressed relative to GAPDH. (F and G) Naive and memory B cells were isolated from three healthy donors and three 
STAT3MUT patients. Ig VH5 genes were cloned and sequenced. (F) The number of mutations detected in each Ig VH5 gene isolated from normal and STAT3MUT 
naive and memory B cells; the horizontal bars represent means. (G) Distribution of mutations in IgV region genes in control and STAT3MUT memory B cells.
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IL-10 (Pène et al., 2004; Bryant et al., 2007; Ettinger et al., 2008). 
For this reason, we next examined the consequences of STAT3 
mutations on the differentiation of naive B cells into ISCs in 
response to these cytokines. CD40L induced few if any nor-
mal naive B cells to differentiate into ISCs (Fig. 6 A). How-
ever, in the presence of CD40L/IL-21, 10% became ISCs as 
determined  by  acquisition  of  a  CD38hiCD27hi  phenotype 
(Fig. 6 A), a differentiation event that correlates with commit-
ment of in vivo– and in vitro–activated human B cells to the 
PC lineage (Ellyard et al., 2004; Avery et al., 2005). In com-
plete contrast, STAT3MUT naive B cells failed to generate ISCs 
after stimulation with CD40L/IL-21 (Fig. 6 B).
Differentiation into ISCs is also linked to cell division 
(Hodgkin et al., 1996; Tangye et al., 2003; Bryant et al., 
sequences from STAT3MUT memory B cells were mutated, 
resulting in a mean of 3 ± 1.33 mutations/sequence (Fig. 5, F 
and G). Restricting analysis to only mutated sequences re-
vealed that the load of mutations was comparable to normal 
memory B cells (i.e., 5.4 ± 2.2 mutations/sequence; n = 13). 
Thus, although fewer memory B cells from AD-HIES pa-
tients expressed mutated Ig  V region genes, SHM can occur at 
a normal rate. This is consistent with intact expression of 
AICDA and isotype switching in STAT3MUT B cells.
STAT3 plays a nonredundant role in mediating  
the differentiation of human naive B cells into ISCs
IL-10 and IL-21 can induce Ig secretion from CD40L-stimulated 
naive B cells, with IL-21 being 10–100 times more efficient than 
Figure 6.  STAT3 but not STAT1 is absolutely required for IL-21–induced differentiation of human naive B cells into ISCs. (A–C) Naive  
B cells from control donors (A) or STAT3MUT patients (B) were labeled with CFSE and cultured with CD40L alone or together with IL-21. After 5 d, the 
percentage of CD38hiCD27hi cells was determined. (C) Percentage of CD38hiCD27hi cells (mean ± SEM; n = 5) generated per division from control and 
STAT3MUT naive B cells stimulated with CD40L/IL-21. (D–G) Naive B cells from healthy controls (D–F: n = 12; G: n = 5), STAT3MUT patients (D–F: n = 7; G: 
n = 5), or STAT1MUT patients (n = 4) were cultured with CD40L alone or together with IL-21 (D–F) or CpG (G). The levels of secreted IgM (D and G), IgG 
(E), and IgA (F) were determined by ELISA after 12 d. Each symbol represents Ig secretion by naive B cells from an individual normal donor or patient; 
the horizontal bars represent means. (H–K) Naive B cells from healthy controls or STAT3MUT or STAT1MUT patients were cultured with CD40L alone (40L) 
or together with IL-21 (+IL21) for 5 d. Expression of PAX5 (H), PRDM1 (I), XBP1 (J), and BCL6 (K) was determined by quantitative PCR. The results are 
means ± SEM (control: n = 12; STAT3MUT: n = 7; or STAT1MUT: n = 3 experiments).JEM VOL. 207, January 18, 2010 
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The failure of STAT3MUT naive B cells to differentiate  
into ISCs in response to IL-21 or IL-10 is caused  
by an inability to undergo the requisite molecular changes 
for commitment to the PC lineage
Commitment of B cells to the PC lineage involves the coor-
dinated actions of several transcription factors. It is initiated 
by the loss of PAX5 (Kallies et al., 2007), followed by induc-
tion of BLIMP-1 and XBP-1, which are required for repres-
sion of the “B cell program” and enforcement of the “PC 
program” of gene expression (Kallies et al., 2007; Tangye and 
Tarlinton, 2009). To elucidate a molecular mechanism for 
the inability of STAT3MUT naive B cells to become ISCs, we 
assessed changes in the expression of PAX5, PRDM1 (encoding 
BLIMP-1), and XBP1 in activated B cells by Q-PCR. Ex-
pression of PAX5 was reduced 3-fold, whereas PRDM1 
and XBP1 were increased 2–10-fold in normal naive B cells 
stimulated with CD40L/IL-21 compared with the expression 
by B cells cultured with CD40L alone (Fig. 6, H–J). In contrast, 
STAT3MUT B cells only modestly down-regulated PAX5 but 
completely failed to acquire PRDM1 and XBP1 after culture 
with CD40L/IL-21 (Fig. 6, H–J), demonstrating an inability 
to undergo the transcriptional changes necessary for the gen-
eration of ISCs. Similar results were observed for normal and 
STAT3MUT B cells cultured with IL-10 (Fig. S2, D and E). In 
complete contrast to STAT3MUT B cells, IL-21 caused naive 
STAT1MUT  B  cells  to  down-regulate  PAX5  and  increase 
PRDM1 and XBP1 to a comparable extent as normal naive 
B cells (Fig. 6, H–J), confirming further that STAT1 is dis-
pensable for this process.
Memory  B  cell  development  largely  occurs  within   
germinal centers (GCs; Tangye and Tarlinton, 2009). The 
paucity of functional memory B cells in STAT3MUT patients 
(Fig. 2, B and C) together with the finding that 50% of 
STAT3MUT memory B cells express unmutated Ig V region 
genes (Fig. 5, F and G) were suggestive of suboptimal GC 
formation in cases of STAT3 mutations. BCL-6 is required 
for GC formation in vivo (Tangye and Tarlinton, 2009) and 
2007). Although the frequency of normal naive B cells that 
became CD38hiCD27hi in response to CD40L/IL-21 in-
creased with division, STAT3MUT naive B cells failed to gen-
erate any ISCs irrespective of division history (Fig. 6 C). 
Secretion  of  IgM  by  normal  naive  B  cells  stimulated   
with CD40L/IL-21 is increased 1,000-fold over that in-
duced by CD40L alone, whereas CD40L/IL-21 induced 
these cells to secrete substantial amounts of IgG and IgA 
(Table I; and Fig. 6, D–F). Consistent with the inability of 
STAT3MUT naive B cells to differentiate into phenotypic 
ISCs in response to CD40L/IL-21, their Ig secretion was 
100–1,000-fold lower than that of corresponding normal   
naive B cells (Table I; Fig. 6, D–F; and Fig. S3). STAT3MUT 
naive B cells were also refractory to the effects of IL-10 
(Table I). These findings were specific for naive B cells 
from patients with STAT3 mutations, because there was 
no significant difference in secretion of IgM, IgG, and IgA 
by STAT1MUT (n = 4) and normal naive B cells in response 
to CD40L/IL-21 (Table I; Fig. 6, D–F; and Table S3). 
Similarly, naive B cells from individuals with high serum 
IgE levels but WT STAT3 alleles (n = 4) secreted 10–200-
fold more Ig in response to CD40L/IL-21 than STAT3MUT 
naive B cells (Table I), whereas CD40L/IL-21 induced nor-
mal Ig production by B cells from CVID patients (n = 11; 
Fig. S3).
The inability of STAT3MUT naive B cells to become 
ISCs in vitro in response to CD40L plus IL-10 or IL-21 
was not caused by a general defect in Ig secretion, because 
they produced normal levels of IgM in response to CD40L/
CpG, which increases IgM secretion induced by CD40L 
alone by 50–100-fold (Fig. 6 G and Table I). Thus, unlike 
isotype switching, STAT3 is absolutely required for IL-10– and 
IL-21–mediated differentiation of naive B cells into ISCs 
in vitro. Furthermore, because the response of STAT1MUT 
B cells was normal, STAT1 is unlikely to make a major 
contribution to this process, highlighting the necessary role 
of STAT3.
Table I.  Impaired Ig secretion by STAT3MUT naive B cells in response to IL-10 and IL-21
Ig secretion
IgM IgG IgA
CD40L +IL-21 +IL-10 +CpG CD40L +IL-21 +IL-10 CD40L +IL-21 +IL-10
ng/ml ng/ml ng/ml ng/ml ng/ml ng/ml ng/ml ng/ml ng/ml ng/ml
Control  
(n = 12)
30 ± 10 30,646 ± 5,344 640 ± 213 3,223 ± 1,023 <0.1 538 ± 193 3.8 ± 2.5 <0.1 3,750 ± 1,440 117 ± 81
STAT3MUT  
(n = 7)
33 ± 15 299 ± 168 47 ± 20 2,382 ± 546 <0.1 4.9 ± 1.6 <0.1 <0.1 1.8 ± 1.7 7.5 ± 7.5
HIES STAT3WT  
(n = 4)
25 ± 13 4,125 ± 955 ND ND <0.1 113 ± 67 ND <0.1 785 ± 484 ND
STAT1MUT  
(n = 4)
45 ± 43 20,706 ± 7,569 715 ± 555 5,314 ± 3,399 <0.1 214 ± 114 ND <0.1 432 ± 275 ND
Naive B cells from the indicated groups were cultured (10 x 103 cells/well/200 µl) with CD40L alone or together with IL-2, IL-10, or CpG. Ig secretion was measured after  
10–12 d. The values are means ± SEM for the indicated number of donors with the exception of cultures of naive B cells from healthy donors or STAT3MUT patients stimulated 
with CD40L/IL-10 or CD40L/CpG (n = 5) and STAT1MUT patients stimulated with CD40L/IL-10 (n = 2). ND, not done.166 STAT3 deficiency impairs B cell differentiation | Avery et al.
2006a,b). Our results complement a recent study that dem-
onstrated overexpression of STAT3 in human B cells induced 
PC differentiation (Diehl et al., 2008), and therefore high-
light a critical role for IL-21 and STAT3 in initiating and/or 
maintaining serological immunity by generating Ag-specific 
effector B cells from naive precursors in vivo. Our data also 
suggest that IL-10 may contribute to this process. However, 
given the differences in the magnitude of the responses in-
duced by IL-10 and IL-21, the effect of IL-10 in vivo is likely 
to be proportionally less than IL-21. IL-6 also activates STAT3 
(Leonard, 2001) and supports Ig secretion by human PCs via 
their heightened expression of the IL-6R (Ellyard et al., 2004; 
Good et al., 2006; Ettinger et al., 2008). Thus, it is plausible 
that IL-6 also contributes to STAT3-mediated regulation of 
human B cell function in vivo.
Induction of AICDA and isotype switching could occur 
despite mutations in STAT1 or STAT3, implying that (a) iso-
type switching is either mediated by residual STAT3 function 
in STAT3MUT B cells, (b) there is functional redundancy be-
tween STAT1 and STAT3, or (c) isotype switching is inde-
pendent of both STAT1 and STAT3 and involves pathways 
such as Akt or mitogen-activated protein kinase (Fig. 7 A; 
Zeng et al., 2007). Irrespective of the mechanism, it is clear that 
Ig isotype switching is unaffected by STAT3 deficiency, which 
contrasts with the dependency of the generation of memory 
B cells and PCs on intact STAT3 function (Fig. 7, A and B).
Germline deletion of Stat3 in mice is embryonically lethal 
(Akira, 1999; Tangye et al., 2009). However, insights into 
STAT3 function in vivo have been provided by generating 
Stat3flox/floxCd19cre mice (Fornek et al., 2006). Some aspects   
of the phenotype of these mice are similar to STAT3MUT  
patients, as both have normal levels of total serum IgM, IgG, 
and IgA but a paucity of Ag-specific Ab (Dreskin et al., 1985; 
Leung et al., 1988; Sheerin and Buckley, 1991; Fornek et al., 
2006). In Stat3flox/floxCd19cre mice, this resulted from an in-
ability to generate Ag-specific IgG-secreting PCs (Fornek et al., 
2006). Interestingly, Il-21r-deficient mice also have a pheno-
type that resembles Stat3flox/floxCd19cre mice and STAT3MUT 
humans: normal levels of serum IgM, IgA, and IgG (although 
IgG1 is variably reduced under some experimental condi-
tions) but impressive reductions in Ag-specific serum IgG1 
titers and splenic PCs (Ozaki et al., 2002). It was unclear 
from this study (Ozaki et al., 2002) whether the humoral im-
mune defect resulted from an intrinsic B cell defect and/or an 
extrinsic defect because of impaired generation of T follicular 
helper cells (Nurieva et al., 2008; Vogelzang et al., 2008). By 
using  a  well-established  model  of  B  cell  differentiation 
(Brink et al., 2008), we found that the Ag-specific (i.e., hen 
egg lysozyme) response of IL-21R–deficient B cells was dras-
tically diminished compared with WT B cells, as indicated by 
a 10–20-fold reduction in the production of hen egg lyso-
zyme–specific PCs and IgM and IgG (Fig. S4, A and B). This 
analysis of in vivo responses of Il21r/ B cells strongly sug-
gests that the key cytokine acting upstream of STAT3 in 
mouse B cells required for intact humoral immune responses 
to TD Ag is IL-21. Together with our in vitro analysis of 
can be induced in B cells by IL-21 (Ettinger et al., 2008). 
Thus, we also examined BCL6 expression. IL-21 induced 
substantial and comparable expression of BCL6 in CD40L-
stimulated naive normal and STAT1MUT B cells. Although 
IL-21 could induce BCL6 in STAT3MUT naive B cells, it was 
10-fold less than that observed for normal and STAT1MUT 
naive B cells (Fig. 6 K). Unlike IL-21, IL-10 did not induce 
BCL6 in naive B cells (Fig. S2, D and E). Thus, the inability 
to generate a sufficient pool of memory B cells in AD-HIES 
may result from inefficient GC reactions.
DISCUSSION
Although it has been appreciated for many years that cyto-
kines can activate specific JAK–STAT signaling pathways in 
B cells (Leonard, 2001; Murray, 2007), contributions of indi-
vidual STATs to the development and effector function of 
primary human B cells have not been established. IL-21 has 
emerged as a key cytokine for establishing, maintaining, and 
regulating the quality of Ab responses (Ozaki et al., 2002; 
Pène et al., 2004; Bryant et al., 2007; Avery et al., 2008a,b; 
Ettinger et al., 2008; Nurieva et al., 2008; Vogelzang et al., 
2008). IL-10 can also induce modest isotype switching and Ig 
secretion from human B cells (Rousset et al., 1992; Brière   
et al., 1994; Bryant et al., 2007). Our detailed analysis of   
IL-10– and IL-21–mediated signaling in human naive B cells 
demonstrated  that  although  these  cytokines  predominantly 
activate STAT1 and STAT3, B cell–intrinsic STAT3 is neces-
sary and sufficient, whereas STAT1 is dispensable, for their es-
tablishment of long-lived, protective Ag-specific Ab responses.
Intact signaling through STAT3 is required to generate 
the memory B cell pool (Fig. 7 B). In contrast, STAT1MUT 
patients could generate normal numbers of memory B cells. 
Studies of female carriers of X-linked severe combined immuno-
deficiency indicated that naive B cells expressed both the 
WT  and  mutant  alleles  of  IL2RG/common    chain  (c), 
whereas memory B cells expressed only the WT allele (Conley 
et al., 1988). This suggested that although signals through c 
were dispensable for B cell development, they were necessary 
for the generation of memory B cells (Conley et al., 1988). In 
light of the findings that memory B cells are dramatically re-
duced in STAT3MUT patients, that IL-21 activates STAT3, 
and that c is a component of the IL-21R (Asao et al., 2001; 
Habib et al., 2002), we propose that IL-21 is a major contributor 
to memory B cell formation and that this occurs through a 
c/STAT3-dependent mechanism.
Although IL-21 activates both STAT1 and STAT3, the 
consequences of DN mutations in STAT3, which reduce 
function by 75%, are much more severe than STAT1 defi-
ciency. Such reduced STAT3 function completely abolished 
IL-21–mediated maturation of naive B cells into ISCs in vitro 
(Fig. 7 A). In contrast, these processes were intact in STAT1MUT 
B cells. These findings mirrored the impaired generation of 
Ag-specific Ab responses noted in AD-HIES patients (Dreskin 
et al., 1985; Leung et al., 1988; Sheerin and Buckley, 1991) 
and the intact Ab responses in cases of STAT1 deficiency after 
standard vaccinations or natural infection (Chapgier et al., JEM VOL. 207, January 18, 2010 
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in AD-HIES, whereas in Stat3flox/floxCd19cre mice, only the 
B cells lack STAT3. Thus, B cell help afforded by other cells 
(CD4+ T cells) may also be impaired in STAT3MUT patients,   
and this may manifest as a more severe defect in humoral   
immunity in humans compared with mice.
The mechanism underlying impaired humoral immune 
responses in STAT3MUT patients was an inability of their   
B cells to activate the molecular machinery necessary for the 
generation of ISCs from naive precursors in response to   
IL-21 (Fig. 7 A). It is important to appreciate that STAT3MUT 
patients do not lack PCs, as they have normal serum Ig levels, 
and we could detect PCs in their lymphoid tissues (Fig. S5 A). 
Thus, STAT3-dependent signaling is crucial for generating 
effective Ag-specific Ab responses but not for maintaining 
total serum Ig levels, which are presumably regulated by 
STAT3-independent pathways such as those downstream of 
STAT3MUT human B cells, this is further evidence of a pivotal 
role of the IL-21R–STAT3 axis in regulating humoral immu-
nity to TD Ag in humans.
Despite these similarities between Stat3flox/floxCd19cre mice 
and STAT3MUT patients, the latter also have reductions in the 
numbers of circulating memory B cells, as well as the levels of 
serum and salivary Ag-specific IgA (Dreskin et al., 1985), 
whereas Stat3flox/floxCd19cre B cells could apparently produce 
Ag-specific IgM and IgA and generate IgG+ memory B cells 
(Fornek et al., 2006). One explanation for these differences is 
that STAT3 deficiency has a more dramatic effect on human 
compared with mouse B cells, which is reminiscent of more 
severe phenotypes in humans with mutations in TYK2, BTK, 
and BLNK compared with gene-targeted mice (Conley   
et al., 2000; Minegishi et al., 2006). Alternatively, these dif-
ferences may reflect the fact that all cells are STAT3 deficient 
Figure 7.  Differential requirement for STAT3 in regulating human B cell differentiation. Naive B cells can be induced to undergo proliferation, isotype 
switching, and differentiation to the PC lineage via distinct pathways: (A) in vitro in response to TD stimulation (CD40L plus IL-21), (B) in vivo in response to  
TD Ag and subsequent GC formation, and (C) in response to TD and T cell–independent stimuli in the form of CD40L and/or BAFF, APRIL, TLR ligands (e.g.,  
viral double-stranded RNA [TLR3] or CpG [TLR9]), and cytokines. Mutations in STAT3 differentially affect each of these pathways (red text). By impairing the  
up-regulation of PRDM1 (BLIMP-1) and XBP1, STAT3MUT B cells are unable to become ISCs in vitro; in contrast, induction of AICDA and Ig isotype switching are 
intact (A). Although GCs can be detected in STAT3MUT patients, the output of memory B cells and efficient PCs, as assessed by reduced numbers of CD27+ B cells 
and serum Ab titers against specific Ag, respectively, is impaired. This may result from reduced induction of BCL6 in response to IL-21. Ig production by STAT3MUT 
B cells in response to STAT3-independent TD and T cell–independent pathways is intact; this may explain the normal serum Ig levels in these patients (C).168 STAT3 deficiency impairs B cell differentiation | Avery et al.
naive B cells into IgE+ B cells (Harris et al., 1999). Interest-
ingly, Bcl6-deficient mice fail to form GCs yet have elevated 
levels  of  IgE  because  of  aberrant  generation  of  IgE-PCs   
resulting from dysregulated IL-4 secretion and signaling via 
STAT6 (Harris et al., 1999; Tangye and Tarlinton, 2009). 
Thus,  reduced  expression  of  BCL6  but  not  AICDA  in 
STAT3MUT B cells and potentially inefficient GC reactions 
in STAT3MUT patients may remove a regulatory circuit that 
ordinarily controls IL-4/STAT6–induced IgE production, 
thereby manifesting as hyper-IgE.
Overall, our data identify STAT3 as the key signaling 
component  downstream  of  the  IL-21R  necessary  for  the 
generation of human memory B cells and ISCs, and thus, 
humoral immune responses. These findings identify a path-
way that results in a clinical phenotype of specific Ab defi-
ciency, and implicate B cell–intrinsic defects in components 
of the IL-21R–STAT3 pathway as candidates underlying im-
paired Ab formation in other immunodeficient conditions.
MATERIALS AND METHODS
mAbs and reagents. The following mAbs were used: FITC–anti-CD20 
and  allophycocyanin  (APC)–anti-CD10  (BD);  biotinylated  anti–human 
IgM, IgG, and IgA; PE–anti-CD27 and anti–phospho-STAT3; APC–anti-
IgG  and  anti-CD38;  streptavidin-PerCp;  PE–anti–IL-10R,  Alexa  Fluor 
488–anti–phospho-STAT5,  Alexa  Fluor  647–anti–phospho-STAT1,  and 
anti–phospho-STAT6 (BD); biotin– and APC–anti-CD27 (eBioscience); 
and PE–anti–IL-21R (R&D Systems).
Human blood and tissue samples. Buffy coats from healthy donors and 
spleens from organ donors were provided by the Australian Red Cross Blood 
Service. PB was collected from patients with STAT3 mutations, patients 
with mutations in STAT1, or patients with CVID or with elevated levels of 
serum IgE but WT STAT3 alleles. The mutations and clinical details of the 
STAT1MUT patients (Dupuis et al., 2001; Chapgier et al., 2006a,b; Chapgier 
et al., 2009), some of the AD-HIES patients (patients 1–5), and the STAT3 
genotyping protocol (Ma et al., 2008) have been previously described; those 
of AD-HIES patients 6–10 are listed in Table S1. All human experiments 
were approved by jurisdictional ethics committees in Canberra, Sydney, 
Melbourne, Adelaide, Brisbane, and Perth, as well as by the institutional   
review boards of the Necker Medical School and the Rockefeller University.
B  cell  phenotyping  and  isolation.  PBMCs  were  incubated  with 
mAb  to  CD20,  CD10,  and  CD27.  The  frequencies  of  transitional 
(CD20+CD10+CD27),  naive  (CD20+CD10CD27),  and  memory 
(CD20+CD10CD27+) B cells were then determined (Wardemann et al., 
2003; Avery et al., 2008b). Expression of Ig isotypes on memory B cells and 
cytokine receptors on naive B cells was determined as previously described 
(Ma et al., 2005; Good et al., 2006; Ma et al., 2006; Avery et al., 2008b). 
B cells were isolated with a Negative Isolation kit (Invitrogen). Naive PB   
B cells were purified by labeling total B cells with mAbs against CD20, CD27, 
and IgG and sorting CD20+CD27IgG cells (FACSAria; BD). The purity 
of the recovered naive population was typically >98%.
Expression of phospho-STATs. Human splenic B cells were cultured 
with CD40L (Tangye et al., 2002) plus F(ab)2 fragments of goat anti–human 
Ig (Jackson ImmunoResearch Laboratories, Inc.) for 24 h, washed, and   
recultured in the absence or presence of 100 ng/ml IL-21 for different   
periods of time before being fixed, permeabilized, and labeled with anti–
phospho-STAT1,  -STAT3,  -STAT5,  and  -STAT6  mAbs  (Avery  et  al., 
2008b). EBV-LCLs established from normal healthy donors and STAT3MUT 
and STAT1MUT patients were stimulated with or without IL-10 or IL-21 for 
30 min, and expression of phospho-STATs was then determined.
BCR, CD40, BAFF-R/TACI, Toll-like receptors (TLRs), 
and specific cytokine receptors (Fig. 7 C). This is supported 
by the ability of human STAT3MUT B cells to isotype switch 
to IL-4 and/or IL-21, and Ig secretion to CpG, and the well-
established roles of TLRs and BAFF/APRIL, together with 
IL-4 or IL-15, in directing Ig isotype switching and secretion 
by human B cells (Litinskiy et al., 2002; Xu et al., 2008).
In contrast to the functional Ab deficit, the explanation 
for the memory B cell deficiency in STAT3MUT patients is 
less clear. Most memory B cells are generated in GCs (Tangye 
and Tarlinton, 2009). Because Stat3flox/floxCd19cre mice can 
form GCs in response to TD Ag (Fornek et al., 2006) and 
GC-like  structures  were  detected  in  the  lymph  node  of 
STAT3MUT patients (Fig. S5 B), a lack of GCs cannot explain 
the paucity of memory B cells in these patients. One possibil-
ity is that STAT3 is required for the survival of memory   
B cells generated from a GC, which is consistent with a   
requirement for STAT3 in protecting mouse B cells from 
apoptosis in vivo (Otero et al., 2006), and that STAT3MUT 
B cells appeared to be less responsive to the prosurvival effects 
of IL-10 than control B cells. Alternatively, STAT3 muta-
tions may result in qualitatively inefficient GC reactions that 
are unable to generate memory B cells and only yield low-
  affinity PCs (Fig. 7 B). This is supported by our findings that 
STAT3MUT memory B cells have a reduced load of SHM, 
Ag-specific  IgG  produced  by  STAT3MUT  patients  was  of   
reduced affinity, and expression of BCL6 by STAT3MUT naive 
B cells in response to IL-21 in vitro was only 10% of that 
observed for normal naive B cells.
Although  STAT3MUT  patients  have  reduced  levels  of 
Ag-specific  IgG  and  IgA,  they  have  aberrantly  high  IgE 
(Grimbacher et al., 2005). Several studies have reported that 
the IgE in AD-HIES patients is Ag specific (Schopfer et al., 
1979; Berger et al., 1980). Although our findings do not 
provide a conclusive explanation for the high level of serum 
IgE conferred by STAT3 mutations, they point to funda-
mental differences in the STAT3 dependence of production/
maintenance of Ag-specific IgM, IgG, and IgA compared 
with Ag-specific IgE. Similarly, our findings indicate that 
STAT3 is crucial for generating high-affinity Ag-specific Ab 
but not for maintaining total serum Ig (Fig. 7). We infer 
from this that STAT3 is important for the formation and/or 
survival of memory B cells and PC-producing IgM, IgG, 
and IgA, and our data represent evidence of the importance 
of IL-21 signaling via STAT3 for the differentiation of GC 
B cells into these effector cells. The corollary is that there is 
a significant contribution to IgE responses from pathways 
outside the GC, which are STAT3 independent. Indeed, 
Erazo et al. (2007) noted that although IgG+ PCs arise from 
GCs, IgE+ PCs were excluded from GCs and localized to 
extrafollicular areas. Furthermore, IgE variable region genes 
exhibit significantly fewer somatic mutations than IgG vari-
able region genes (Dahlke et al., 2006), which suggests that 
IgE+ B cells are not selected within GCs. These observations 
are consistent with the ability of BCL-6 (expressed by GC 
B cells) to inhibit IL-4/STAT6–mediated differentiation of JEM VOL. 207, January 18, 2010 
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stimulated normal and STAT3MUT naive B cells. Fig. S3 shows Ig secretion 
by CD40L- and CD40L/IL-21–stimulated B cells from normal donors and 
CVID patients. Fig. S4 shows impaired responses of Il21r-deficient mouse   
B cells in vivo after challenge with specific Ag. Fig. S5 shows the presence   
of PCs and GC-like structures in lymphoid tissues of AD-HIES patients.   
Online supplemental material is available at http://www.jem.org/cgi/ 
content/full/jem.20091706/DC1.
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